Athanor Capital, LP Xencor Inc Transaction History

Athanor Capital, LP

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2021 May 14, 2021	SELL	$40.81 - $53.88 $642,961 - $848,879	-15,755 Closed	0 $0
Q4 2020 Feb 16, 2021	SELL	$36.63 - $47.63 $443,589 - $576,799	-12,110 Reduced 43.46%	15,755 $687,000
Q3 2020 Nov 16, 2020	SELL	$30.09 - $43.02 $365,142 - $522,047	-12,135 Reduced 30.34%	27,865 $1.08 Million
Q2 2020 Aug 13, 2020	BUY	$27.76 - $33.42 $1.11 Million - $1.34 Million	40,000 New	40,000 $1.3 Million

215

71.8M

2.5K

7.9K

Ticker XNCR
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 59,698,100
Market Cap $1.49B
Description
Xencor, Inc., a clinical stage biopharmaceutical company, focuses on the discovery and development of engineered monoclonal antibody and cytokine therapeutics to treat patients with cancer and autoimmune diseases. The company provides Sotrovimab that targets the SARS-CoV-2 virus; Ultomiris for the treatment of patients with paroxysmal nocturnal ...

Get notified when there are updates to the investment portfolio of Athanor Capital, LP, based on Form 13F filings with the SEC.

Stay updated on Athanor Capital, LP with notifications on news.